These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. [Investigations in the use of mogramostime (GM-CSF) in patients with acute leukemia]. Paśnicki M. Wiad Lek; 1995; 48(1-12):194-7. PubMed ID: 9638239 [No Abstract] [Full Text] [Related]
3. Adult acute lymphocytic leukemia: the Eastern Cooperative Oncology Group experience. Cassileth PA, Andersen JW, Bennett JM, Hoagland HC, Mazza JJ, O'Connell MC, Paietta E, Wiernik P. Leukemia; 1992; 6 Suppl 2():178-81. PubMed ID: 1578927 [No Abstract] [Full Text] [Related]
4. Follow-up of the first two successive German multicentre trials for adult ALL (01/81 and 02/84). German Adult ALL Study Group. Hoelzer D, Thiel E, Ludwig WD, Löffler H, Büchner T, Freund M, Heil G, Hiddemann W, Maschmeyer G, Völkers B. Leukemia; 1993 Aug; 7 Suppl 2():S130-4. PubMed ID: 8361217 [No Abstract] [Full Text] [Related]
5. Treatment of acute lymphoblastic leukemia French protocol Fralle 83-87. Schaison G, Sommelet D, Bancillon A, Perel Y, Leblanc T, Bergeron C, Lejars O, Baruchel A, Lepage E, Leverger G. Leukemia; 1992 Aug; 6 Suppl 2():148-52. PubMed ID: 1578919 [No Abstract] [Full Text] [Related]
7. Results of the PETHEMA ALL-96 trial in elderly patients with Philadelphia chromosome-negative acute lymphoblastic leukemia. Sancho JM, Ribera JM, Xicoy B, Morgades M, Oriol A, Tormo M, del Potro E, Debén G, Abella E, Bethencourt C, Ortín X, Brunet S, Ortega-Rivas F, Novo A, López R, Hernández-Rivas JM, Sanz MA, Feliu E, PETHEMA Group. Eur J Haematol; 2007 Feb; 78(2):102-10. PubMed ID: 17087744 [Abstract] [Full Text] [Related]
8. [Treatment of acute lymphoblastic leukemia in children. Results of the FRALLE 83 protocol]. Bancillon A. Arch Fr Pediatr; 1991 Oct; 48(8):593-4. PubMed ID: 1768205 [No Abstract] [Full Text] [Related]
9. Poor outcome of intensive chemotherapy for adult acute lymphoblastic leukemia: a possible dose effect. Chiu EK, Chan LC, Liang R, Lie A, Kwong YL, Todd D, Chan TK. Leukemia; 1994 Sep; 8(9):1469-73. PubMed ID: 8090027 [Abstract] [Full Text] [Related]
10. Variant translocations of 11q23 in infant acute lymphoblastic leukemia (ALL): do outcomes differ from t(4;11)? Jakab Z, Balogh E, Karászi E, Kappelmayer J, Kiss C, Oláh E. Med Pediatr Oncol; 2002 Jul; 39(1):63-5. PubMed ID: 12116086 [No Abstract] [Full Text] [Related]
11. [Treatment of various types of acute leukemia in adult. An analysis of 98 cases. The Leukemia Cooperation Group of Beijing City]. Zhonghua Nei Ke Za Zhi; 1992 Mar; 31(3):139-42, 187. PubMed ID: 1395923 [Abstract] [Full Text] [Related]
12. [Adult acute lymphoblastic leukemia: preliminary results of the LAL-86 protocol]. Ribera JM, Grañena A, Rozman C, Urbano-Ispizua A, Bladé J, Carreras E, Cervantes F, Marín P, Sierra J, Nomdedeu B. Sangre (Barc); 1990 Feb; 35(1):26-32. PubMed ID: 2333581 [Abstract] [Full Text] [Related]
13. Parotid mucoepidermoid carcinoma following chemotherapy for childhood acute lymphoblastic leukemia. Sandoval C, Jayabose S. Pediatr Hematol Oncol; 2001 Feb; 18(3):217-20. PubMed ID: 11293291 [Abstract] [Full Text] [Related]
14. Additional chromosomal abnormalities and their prognostic significance in adult Philadelphia-positive acute lymphoblastic leukemia: with or without imatinib in chemotherapy. Li Y, Qiu L, Zou D, Zhao Y, Mi Y, Wang J. Ann Hematol; 2009 Nov; 88(11):1069-77. PubMed ID: 19277658 [Abstract] [Full Text] [Related]
15. [Preliminary evaluation of the treatment of recurrences of acute lymphoblastic leukemia by the BFM (Henze) method]. Ochocka M, Zelenay E. Pediatr Pol; 1988 Nov; 63(11):716-22. PubMed ID: 3253658 [No Abstract] [Full Text] [Related]
16. [Acute lymphoblastic leukemia in children with initial leucocytosis above 50,000/mm3: summary of treatment results of Polish Pediatric Leukemia/Lymphoma Study Group]. Skoczeń S, Balwierz W, Moryl-Bujakowska A, Pawińska K, Luszczyńska A, Balcerska A, Płoszyńska A, Chybicka A, Dobaczewski G, Juszczak K, Wachowiak J, Derwich K, Kowalczyk J, Wiśniewska-Slusarz H, Matysiak M, Krauze A, Pawelec K, Sońta-Jakimczyk D, Tomaszewska R, Wysocki M, Styczyńskii J, Swiatkiewicz V, Polish Pediatric Leukemia/Lymphoma Study Group. Przegl Lek; 2006 Nov; 63(1):11-4. PubMed ID: 16892892 [Abstract] [Full Text] [Related]
17. Comparison of the results of the treatment of adolescents and young adults with standard-risk acute lymphoblastic leukemia with the Programa Español de Tratamiento en Hematología pediatric-based protocol ALL-96. Ribera JM, Oriol A, Sanz MA, Tormo M, Fernández-Abellán P, del Potro E, Abella E, Bueno J, Parody R, Bastida P, Grande C, Heras I, Bethencourt C, Feliu E, Ortega JJ. J Clin Oncol; 2008 Apr 10; 26(11):1843-9. PubMed ID: 18398150 [Abstract] [Full Text] [Related]
18. Childhood acute lymphoblastic leukaemia: outcomes of 54 consecutive patients treated in Auckland 1985-1991. Mauger DC, Skeen JE. N Z Med J; 1998 Nov 27; 111(1078):454-6. PubMed ID: 9891565 [Abstract] [Full Text] [Related]
19. Fractionated cyclophosphamide added to the IVAP regimen (idarubicin-vincristine-L-asparaginase-prednisone) could lower the risk of primary refractory disease in T-lineage but not B-lineage acute lymphoblastic leukemia: first results from a phase II clinical study. Bassan R, Pogliani E, Lerede T, Fabris P, Rossi G, Morandi S, Casula P, Lambertenghi-Deliliers G, Vespignani M, Izzi T, Coser P, Corneo G, Barbui T. Haematologica; 1999 Dec 27; 84(12):1088-93. PubMed ID: 10586210 [Abstract] [Full Text] [Related]
20. An update of the results of intensive therapy in children with acute lymphoblastic leukemia. Pavlovsky S, Sackmann Muriel F, Santarelli MT, Svarch E, Jiménez E, Kohan R, Rosso A. Leukemia; 1992 Dec 27; 6 Suppl 2():167-70. PubMed ID: 1578923 [Abstract] [Full Text] [Related] Page: [Next] [New Search]